Clinical Trial Update: Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating local consolidation after treatment with Sintilimab plus Lenvatinib for metastatic liver cancer; the study is currently not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• LENVIMA (lenvatinib)
• Tyvyt (Sintilimab) (Sintilimab)

Snippet

Sponsor: Tongji Hospital | Conditions: Hepatocellular Carcinoma (HCC), Metastases | Phase 3 | Status: NOT_YET_RECRUITING